Proposed Collection; 60-Day Comment Request; A Generic Submission for Formative Research, Pre-Testing, Stakeholder Measures and Advocate Forms at NCI, 42023 [2014-16908]
Download as PDF
<![CDATA[
42023
Federal Register / Vol. 79, No. 138 / Friday, July 18, 2014 / Notices
IV. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at either
https://www.fda.gov/BiologicsBlood
Vaccines/GuidanceCompliance
RegulatoryInformation/Guidances/
default.htm or https://www.
regulations.gov.
Dated: July 14, 2014.
Peter Lurie,
Associate Commissioner for Policy and
Planning.
[FR Doc. 2014–16931 Filed 7–17–14; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment
Request; A Generic Submission for
Formative Research, Pre-Testing,
Stakeholder Measures and Advocate
Forms at NCI
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Cancer Institute (NCI),
National Institutes of Health (NIH), will
publish periodic summaries of proposed
projects to be submitted to the Office of
Management and Budget (OMB) for
review and approval.
Written comments and/or suggestions
from the public and affected agencies
are invited on one or more of the
following points: (1) Whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) The accuracy of the
and materials while they are under
development. Additionally,
administrative forms are a necessary
part of collecting demographic
information and areas of interest for
advocates. Pre-testing, or formative
evaluation, helps ensure that the
products and services developed by NCI
have the greatest capacity of being
received, understood, and accepted by
their target audiences. Since OAR is
responsible for matching advocates to
NCI programs and initiatives across the
cancer continuum, it is necessary to
measure the satisfaction of both internal
and external stakeholders with this
collaboration. This customer satisfaction
research helps ensure the relevance,
utility, and appropriateness of the many
initiatives and products that OAR and
NCI produce. The OAR will use a
variety of qualitative (focus groups,
interviews) and quantitative (paper,
phone, in-person, and web surveys)
methodologies to conduct this research,
allowing NCI to: (1) Understand
characteristics (attitudes, beliefs, and
behaviors) of the intended target
audience and use this information in the
development of effective strategies,
concepts, activities; (2) use a feedback
loop to help refine, revise, and enhance
OAR’s efforts—ensuring that they have
the greatest relevance, utility,
appropriateness, and impact for/to
target audiences; and (3) expend limited
program resource dollars wisely and
effectively. The anticipated individual
respondents will consist of: Adult
cancer research advocates, members of
the public, health care professionals,
and organizational representatives.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
1,025.
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used; (3)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; and (4) Ways to minimize the
burden of the collection of information
on those who are to respond, including
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
To Submit Comments and for Further
Information: To obtain a copy of the
data collection plans and instruments,
submit comments in writing, or request
more information on the proposed
project, contact: Kelley Landy, Acting
Director of the Office of Advocacy
Relations (OAR), NCI, NIH, 31 Center
Drive, Bldg. 31, Room 10A28, MSC
2580, Bethesda, MD 20892, call nontoll-free number 301–594–3194, or
email your request, including your
address, to kelley.landy@mail.nih.gov.
Comment Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Proposed Collection: A Generic
Submission for Formative Research, Pretesting, Stakeholder Measures and
Advocate Forms at NCI, 0925–0641,
Revision, National Cancer Institute
(NCI), National Institutes of Health
(NIH).
Need and Use of Information
Collection: The Office of Advocacy
Relations (OAR) disseminates cancerrelated information to a variety of
stakeholders, seeks input and feedback,
and facilitates collaboration to advance
NCI’s authorized programs. It is
beneficial for NCI, through the OAR, to
pretest strategies, concepts, activities
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Individuals .....................
sroberts on DSK5SPTVN1PROD with NOTICES
Respondent type
Self-Administered Questionnaires .......................
Individual In-Depth Interviews ..............................
Focus Group Interviews .......................................
Dated: July 14, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–16908 Filed 7–17–14; 8:45 am]
BILLING CODE 4140–01–P
800
75
100
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Mar<15>2010
23:20 Jul 17, 2014
Jkt 232001
PO 00000
Frm 00070
Fmt 4703
Sfmt 4703
Frequency of
response
1
1
1
Average time
per response
(minutes/hour)
Annual burden
hours
1
1
90/60
800
75
150
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
E:\FR\FM\18JYN1.SGM
18JYN1
]]>Agencies
[Federal Register Volume 79, Number 138 (Friday, July 18, 2014)]
[Notices]
[Page 42023]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-16908]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; A Generic Submission
for Formative Research, Pre-Testing, Stakeholder Measures and Advocate
Forms at NCI
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the National
Cancer Institute (NCI), National Institutes of Health (NIH), will
publish periodic summaries of proposed projects to be submitted to the
Office of Management and Budget (OMB) for review and approval.
Written comments and/or suggestions from the public and affected
agencies are invited on one or more of the following points: (1)
Whether the proposed collection of information is necessary for the
proper performance of the function of the agency, including whether the
information will have practical utility; (2) The accuracy of the
agency's estimate of the burden of the proposed collection of
information, including the validity of the methodology and assumptions
used; (3) Ways to enhance the quality, utility, and clarity of the
information to be collected; and (4) Ways to minimize the burden of the
collection of information on those who are to respond, including the
use of appropriate automated, electronic, mechanical, or other
technological collection techniques or other forms of information
technology.
To Submit Comments and for Further Information: To obtain a copy of
the data collection plans and instruments, submit comments in writing,
or request more information on the proposed project, contact: Kelley
Landy, Acting Director of the Office of Advocacy Relations (OAR), NCI,
NIH, 31 Center Drive, Bldg. 31, Room 10A28, MSC 2580, Bethesda, MD
20892, call non-toll-free number 301-594-3194, or email your request,
including your address, to kelley.landy@mail.nih.gov.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60 days
of the date of this publication.
Proposed Collection: A Generic Submission for Formative Research,
Pre-testing, Stakeholder Measures and Advocate Forms at NCI, 0925-0641,
Revision, National Cancer Institute (NCI), National Institutes of
Health (NIH).
Need and Use of Information Collection: The Office of Advocacy
Relations (OAR) disseminates cancer-related information to a variety of
stakeholders, seeks input and feedback, and facilitates collaboration
to advance NCI's authorized programs. It is beneficial for NCI, through
the OAR, to pretest strategies, concepts, activities and materials
while they are under development. Additionally, administrative forms
are a necessary part of collecting demographic information and areas of
interest for advocates. Pre-testing, or formative evaluation, helps
ensure that the products and services developed by NCI have the
greatest capacity of being received, understood, and accepted by their
target audiences. Since OAR is responsible for matching advocates to
NCI programs and initiatives across the cancer continuum, it is
necessary to measure the satisfaction of both internal and external
stakeholders with this collaboration. This customer satisfaction
research helps ensure the relevance, utility, and appropriateness of
the many initiatives and products that OAR and NCI produce. The OAR
will use a variety of qualitative (focus groups, interviews) and
quantitative (paper, phone, in-person, and web surveys) methodologies
to conduct this research, allowing NCI to: (1) Understand
characteristics (attitudes, beliefs, and behaviors) of the intended
target audience and use this information in the development of
effective strategies, concepts, activities; (2) use a feedback loop to
help refine, revise, and enhance OAR's efforts--ensuring that they have
the greatest relevance, utility, appropriateness, and impact for/to
target audiences; and (3) expend limited program resource dollars
wisely and effectively. The anticipated individual respondents will
consist of: Adult cancer research advocates, members of the public,
health care professionals, and organizational representatives.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1,025.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Respondent type Form name Number of Frequency of per response Annual burden
respondents response (minutes/hour) hours
----------------------------------------------------------------------------------------------------------------
Individuals................... Self- 800 1 1 800
Administered
Questionnaires.
Individual In- 75 1 1 75
Depth
Interviews.
Focus Group 100 1 90/60 150
Interviews.
----------------------------------------------------------------------------------------------------------------
Dated: July 14, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2014-16908 Filed 7-17-14; 8:45 am]
BILLING CODE 4140-01-P
